Pathogenesis and inflammaging in MDS [MDS Professional Report]
Dr. Moshe Mittelman is hosting the world-leading expert Dr. Michael Savona and they have an attractive conversation on several mechanisms in...
Radio and PodcastLive Radio & Podcasts
Health
MDS Professional Report
This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.The explosion of information on MDS forces us to seek novel, a...
MDS Professional Report Podcast Guide
Listen to MDS Professional Report, a Health podcast by PI Media. Stream 13 episodes in English, follow new audio stories, and play episodes online on Radio and Podcast.
Show Topic
Browse this show under Health podcasts.
Episodes
13 episodes are available for this podcast.
Discover More
Explore Health podcasts, United States podcasts and English podcasts.
Episodes
13 episodes
Treatment of lower-risk MDS [MDS Professional Report]
Prof. Uwe Platzbecker from Leipzig and Prof. Moshe Mittelman from Tel-Aviv in an interesting conversation on the various available therapeut...
Treatment for Higher-risk MDS [MDS Professional Report]
Prof. Nicolaus Kröger from Hamburg and Prof. Moshe Mittelman from Tel-Aviv, in a stimulating conversation on the various therapeutic modalit...
Update on Higher-Risk MDS - Lessons from 2023 ASH [MDS Professional Report]
Dr. Nicolaos Papadantonakis from Emory Atlanta and Dr. Moshe Mittelman from Tel-Aviv, describe several updated abstracts from 2023 ASH with...
New trials to address the anemia of lower-risk MDS [MDS Professional Report]
Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss trials presented in American Society of He...
Transfusions and quality of life [MDS Professional Report]
Prof. Rena Buckstein from Toronto, and Prof. Moshe Mittelman from Tel-Aviv discuss issues related to RBC transfusions, the hemoglobin thresh...
Bone marrow failure disorders in childhood [MDS Professional Report]
Prof. Akiko Shimamura of Harvard Medical School, Boston, a world known expert of pediatric hematology discusses with Prof. Guillermo Sanz ,o...
The role of genetics in MDS management [MDS Professional Report]
Drs. Rafael Bejar (San Diego) and Moshe Mittelman (Tel Aviv) discuss several papers highlighting the role of genetics in MDS diagnosis, foll...
MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report]
Drs. Moshe Mittelman, of The Tel Aviv Sourasky Medical Center, and Drorit Merkel, of the Sheba Medical Center, both from Tel Aviv University...
Do immune check inhibitors have a role in the treatment of higher-risk MDS? [MDS Professional Report]
Chien Aza – Pembro - BJH The combination of azacitidine and pembrolizumab may be a potential effective regimen for patients with higher-risk...
Will Venetoclax Become The New Standard? [MDS Professional Report]
We will discuss the addition of venetoclax to hypomethylating agents in the treatment of advanced myeloid neoplasms, especially higher-risk...
Don't withhold anti-neoplastic treatment from your hematological patients infected by COVID [MDS Professional Report]
PAPER 1Authors: Vijenthira A. et al. (Princess Margaret, Toronto)Title: Outcomes of patients with hematologic malignancies and COVID-19: a s...
TP53 mutations – were they born equal [MDS Professional Report]
Bernard E et al: In the first presented study, Dr. Elza Bernard and colleagues deliver an important lesson about the high-risk mutation TP53...